INVION LIMITED — Major Shareholding Notification 2010

Mar 24, 2010

15 July 2001 604 page 1/2

Form 604

Corporations Act 2001 Section 671B

	Notice of change of interests of substantial holder
To Company Name/Scheme	CBio Limited
ACN/ARSN	094 730 417

1. Details of substantial holder (1)

DR MICHAEL MONSOUR

ACN/ARSN (if applicable)

Name

There was a change in the interests of the substantial holder on The previous notice was given to the company on The previous notice was dated

23/03/10 25/02/10 25/02/10

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4)	Previous notice		Present notice
	Person's votes	Voting power (5)	Person's votes	Voting power (5)
ORDINARY SHARES	8,757,433	ነ12%	6,209,408	19%

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Person whose relevant interest changed	Nature of change $(6)$	Consideration given in relation to change (7)	Class and number of secunties	Person's votes affected
AUSTRALIAN TECHNOLOGY INNOVATION FUND LIMITED	IN SPECIE ENSTRIBUTION OF ICBIO SHARES	INIL.	k3,004,843)	(3.004.843)
DR MICHAEL MONSOUR	RECEIPT OF ISHARES AS PART OF ATIF IN SPECIE	NIL.	138.187	38,187
MP MONSOUR IMEDICAL PRACTICE PTY LTD	OF ATIF IN SPECIE DISTRIBUTION		7,272	7.272
MPAMM PTY LTD		NIL	173,516	173,516
DR MICHAEL FOUNDATION A/C>	LOISTRIBUTION		337843	337,843
		IDISTRIBUTION RECEIPT OF ISHARES AS PART RECEIPT OF ISHARES AS PART IOF ATIF IN SPECIE DISTRIBUTION IRECEIPT OF MONSOUR <spyder as="" partOF ATIF IN SPECIE	ÍNIL. Inil.	sflected

$\ddot{\phantom{a}}$

$\ddot{\phantom{0}}$

$\bar{1}$

l,

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevant merest	Registered holder of securities	Person entitled to be registered as holder (8)	Nature of relevant interest (6)	Class and mimber of securities	Person's votes
DR MICHAEL Imonsour	DR MICHAEL MONSOUR	DR MICHAEL MONSOUR	lBeneficial owner	138,167	38,187
IDR MICHAEL IMONSOUR	MP MONSOUR MEDICAL PRACTICE MEDICAL FRANCTIC MEDICAL PTY LTD <super fund="" ltdWC>	MP MONSOUR	Director & shareholder	1,057,480	1.057.480
DR MICHAEL imonsour	IMPAMM PTY LTD	IMPAMM PTY LTD	Director & shareholder	14.307.590	4.307.590
DR MICHAEL IMONSOUR	AUSTRALIAN TECHNOLOGY IINNOVATION FUND IUMITED	IAUSTRALIAN TECHNOLOGY LIMITED	HNNOVATION FUND Director & shareholder	368,755	1368.755
DR MICHAEL IMONSOUR	IAUSTRALIAN BIOFUNDS INVESTMENTS IUMITED	AUSTRALIAN BIOFUNDS IINVESTMENTS ILIMITED	Director & shareholder	199,553	199.553
IDR MICHAEL IMONSOUR	DR MICHAEL MONSOUR <spyder spyderFOUNDATION A/C>	FOUNDATION	Registered holder (in error)	1337.843	1337,843

$\bar{z}$

15 July 2001 604 page 2/2

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

ACN/ARSN Name ard applicable)	-ff	Nature of association
IN/A		IN/A

6. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Dr Michael Monsour	297 Kent Street Maryborough Qtd 4065
MPAMM Pty Ltd	297 Kent Street Maryborough Qld 4065
M P Monsour Medical Practice Super Fund	297 Kent Street Maryborough Old 4065
Australian Technology Innovation Fund Limited	85 Brandi St Eight Mile Plains Qld 4113
Australian Biofund Investments Limited	PO Box 3104 South Brisbane 4101

Signature

print name DR MICHAEL MONSOUR		CSDSCIV
sign here 22	Mano our	date	$23^{7}$ 3/10

DIRECTIONS

• If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and
  trustee of an equity trust), the names could be included in an ann $(1)$ they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
• $(2)$ See the definition of "associate" in section 9 of the Corporations Act 2001.
• $(3)$ See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
• $(4)$ The voting shares of a company constitute one class unless divided into separate classes.
• The person's votes divided by the total votes in the body corporate or scheme multiplied by 100. $(5)$
• $(6)$ Include details of
• any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy (a) any relevant agreement or ower unconstances occurse or minds are enargy in relevant more experience. It sessions that is of any contract, of any contract, or any contract, or any contract, solidy experience and an environment and recording environment and a securities of the person group and to secure or any construction of any construction of any construction of any construction of any construction of any c
• $(b)$ any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating dearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001,

• Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may,
  become entitled to receive in relation to that acquisition. Details m $(7)$ contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
• If the substantial holder is unable to determine the identity of the person (eg. if the relevant Interest arises because of an option) write "unknown". $(8)$
• Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice. $(9)$